Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 3284 entries
View as:

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00233636 Org: User:
Start: 07/31/03 End: - Due: -

Effects of Single Oral Dose Dapagliflozin QT Study

Phase: N/A Priority: Normal
NCT ID: NCT00688493 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09

Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT01140542 Org: User:
Start: 08/31/06 End: 03/31/08 Due: 03/31/09

Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01203904 Org: User:
Start: 09/30/10 End: 09/30/15 Due: 09/30/16

Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03532009 Org: User:
Start: 06/26/18 End: 05/22/20 Due: 05/22/21

A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04765059 Org: User:
Start: 09/12/21 End: 12/29/25 Due: 12/29/26

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00727883 Org: User:
Start: 07/31/07 End: 05/31/08 Due: 05/31/09

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

Phase: N/A Priority: Normal
NCT ID: NCT00660764 Org: User:
Start: 05/31/03 End: 04/30/05 Due: 04/30/06

Long-Term Safety of Symbicort in Asthmatic Children - SAPLING

Phase: N/A Priority: Normal
NCT ID: NCT00646529 Org: User:
Start: 07/31/02 End: 10/31/03 Due: 10/31/04

Badalona Major Depressive Disorder Database Study

Phase: N/A Priority: Normal
NCT ID: NCT01446692 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01206231 Org: User:
Start: 12/31/10 End: 10/31/11 Due: 10/31/12

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02695121 Org: User:
Start: 01/01/17 End: 01/30/25 Due: 01/30/26

Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02179671 Org: User:
Start: 07/25/14 End: 06/11/16 Due: 06/11/17

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Phase: N/A Priority: Normal
NCT ID: NCT03944772 Org: User:
Start: 06/25/19 End: 05/06/25 Due: 05/06/26

Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06827132 Org: User:
Start: 03/15/25 End: 05/31/27 Due: 05/31/28

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04538742 Org: User:
Start: 12/28/20 End: 01/31/30 Due: 01/31/31

IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01392482 Org: User:
Start: 07/31/11 End: 09/30/12 Due: 09/30/13

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00638391 Org: User:
Start: 05/31/05 End: 03/31/07 Due: 03/31/08

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT06008353 Org: User:
Start: 01/18/24 End: 08/31/26 Due: 08/31/27

Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT02288273 Org: User:
Start: 12/31/14 End: 08/31/15 Due: 08/31/16

AZD4635 Relative Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT03710434 Org: User:
Start: 11/01/18 End: 04/02/19 Due: 04/02/20

Non-Interventional Study PREVENT

Phase: N/A Priority: Normal
NCT ID: NCT02155998 Org: User:
Start: 07/16/14 End: 12/14/16 Due: 12/14/17

A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

Phase: N/A Priority: Normal
NCT ID: NCT03169959 Org: User:
Start: 05/29/17 End: 08/03/17 Due: 08/03/18

Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01365000 Org: User:
Start: 06/30/11 End: 08/31/11 Due: 08/31/12

Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)

Phase: N/A Priority: Normal
NCT ID: NCT00937066 Org: User:
Start: - End: - Due: -